In a guest post on “The MS Blog,” Dr Oliver Findling summarised a recent study on which he was the principal investigator: Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis. Read more: https://www.brainwork.md/what-are-the-implications-for-the-third-covid-19-vaccine-on-cd-20-depleted-people-with-ms-oliver-findling-reports/

What motivated Prof. Mary Reilly to start a career in #neurobiology, what kind of #research projects is she involved in and what are her thoughts on women’s #career chances for high-level positions? Read her answers to these questions & more on Brainwork: https://bit.ly/3JU52tc

New PB-TURSO shows benefit in overall survival for patients with #ALS. Read the full article: https://www.brainwork.md/long-term-survival-of-participants-in-the-centaur-trial-of-sodium-phenylbutyrate-taurursodiol-in-amyotrophic-lateral-sclerosis/

Inflammation is not only present in acute and relapsing #multiplesclerosis (MS), but also in the secondary and progressive disease. At #ECTRIMS 2021, Dr Fox, (Cleveland Clinic) discussed the impact of smouldering inflammation in #MS: https://bit.ly/3w4Q7Wp

At least 2/3 of cases of #neuromyelitis optica spectrum disorder (#NMOSD) are associated with AQP4-IgG and complement-mediated CNS damage. At ECTRIMS 2021, Prof. Wingerchuk (Mayo Clinic) presented long-term data on #eculizumab for AQP4-positive NMOSD. https://bit.ly/3BEESp2